Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 9

Results For "NHA"

2110 News Found

ABB’s ACS360 Drives enhance safety and energy efficiency at Bharat Biotech’s Covaxin plant
Biotech | September 07, 2021

ABB’s ACS360 Drives enhance safety and energy efficiency at Bharat Biotech’s Covaxin plant

ABB Drives play a key role in the cleanroom infrastructure of Bharat Biotech, India’s first indigenous Covid-19 vaccine manufacturer. The drives are easy to commission, use and ensure higher energy efficiency


Medtronic partners with Stasis to enhance patient monitoring in India
Digitisation | September 02, 2021

Medtronic partners with Stasis to enhance patient monitoring in India

The Stasis connected care monitoring system includes - a bedside monitor that monitors 6 vital signs, a tablet that enables intuitive monitoring, and the Stasis app that allows for remote monitoring across devices


Glenmark receives ANDA approval for inhalation solution
News | June 24, 2021

Glenmark receives ANDA approval for inhalation solution

Arformoterol Tartrate Inhalation Solution, 15 mcg/2 mL, Unit-Dose Vials will be manufactured in the company’s North American manufacturing facility based in Monroe, North Carolina


Nanoform and Celanese explore ways to enhance drug delivery
News | May 25, 2021

Nanoform and Celanese explore ways to enhance drug delivery

Nanoform and Celanese intend to work on formulation development, leveraging each organization's unique formulation expertise.


WHO declares Ebola outbreak, Indians advised against travel to affected regions
Public Health | May 25, 2026

WHO declares Ebola outbreak, Indians advised against travel to affected regions

No approved vaccine or specific treatment currently available for Bundibugyo strain Ebola disease


Enveric reports key safety milestone for EB-003 reinforcing clinical development path
Biotech | May 25, 2026

Enveric reports key safety milestone for EB-003 reinforcing clinical development path

The findings support the continued advancement of EB-003, a first-in-class neuroplastogen designed to selectively target both 5-HT2A and 5-HT1B receptors


Health ministry classifies Pregabalin under Schedule H1 to curb misuse
Policy | May 23, 2026

Health ministry classifies Pregabalin under Schedule H1 to curb misuse

New regulation mandates stricter prescription monitoring, sales record maintenance, and enhanced compliance across the pharmaceutical supply chain


Merck doses first patient in Phase 3 trial of novel antibody-drug conjugate for metastatic colorectal cancer
Clinical Trials | May 23, 2026

Merck doses first patient in Phase 3 trial of novel antibody-drug conjugate for metastatic colorectal cancer

The trial will assess Precem-TcT, both as monotherapy and in combination with bevacizumab, in patients whose disease has progressed after or become resistant to standard treatments


Gujarat Themis Biosyn acquires MicroBiopharm Japan for Rs. 1,300 Cr
News | May 23, 2026

Gujarat Themis Biosyn acquires MicroBiopharm Japan for Rs. 1,300 Cr

Transition to a fermentation-based globally integrated CDMO platform


Alembic Pharma elevates Karunanithi Ponnusamy as President of Animal Health Business
People | May 22, 2026

Alembic Pharma elevates Karunanithi Ponnusamy as President of Animal Health Business

Pharma veteran with over three decades of industry experience to lead Alembic’s animal health growth and market expansion initiatives.